Literature DB >> 17703841

12 months cinacalcet therapy in hemodialysis patients with secondary hyperparathyroidism: effect on bone markers.

G Jean, C Chazot, B Charra.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17703841     DOI: 10.5414/cnp68063

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


× No keyword cloud information.
  7 in total

1.  The efficacy of cinacalcet combined with conventional therapy on bone and mineral metabolism in dialysis patients with secondary hyperparathyroidism: a meta-analysis.

Authors:  Dan Li; Leping Shao; Haiyan Zhou; Wei Jiang; Wei Zhang; Yan Xu
Journal:  Endocrine       Date:  2012-06-06       Impact factor: 3.633

Review 2.  The calcium-sensing receptor in bone--mechanistic and therapeutic insights.

Authors:  David Goltzman; Geoffrey N Hendy
Journal:  Nat Rev Endocrinol       Date:  2015-03-10       Impact factor: 43.330

Review 3.  The role of the calcium-sensing receptor in bone biology and pathophysiology.

Authors:  T A Theman; M T Collins
Journal:  Curr Pharm Biotechnol       Date:  2009-04       Impact factor: 2.837

4.  Cinacalcet lowers serum alkaline phosphatase in maintenance hemodialysis patients.

Authors:  Vasily Belozeroff; William G Goodman; Lulu Ren; Kamyar Kalantar-Zadeh
Journal:  Clin J Am Soc Nephrol       Date:  2009-03-04       Impact factor: 8.237

5.  Long-term cinacalcet HCl treatment improved bone metabolism in Japanese hemodialysis patients with secondary hyperparathyroidism.

Authors:  Takashi Shigematsu; Tadao Akizawa; Eiji Uchida; Yusuke Tsukamoto; Manabu Iwasaki; Shouzo Koshikawa
Journal:  Am J Nephrol       Date:  2008-09-17       Impact factor: 3.754

6.  Severe secondary hyperparathyroidism in patients on haemodialysis is associated with a high initial serum parathyroid hormone and beta-CrossLaps level: Results from an incident cohort.

Authors:  Guillaume Jean; Marie Hélène Lafage-Proust; Jean Claude Souberbielle; Sylvain Lechevallier; Patrik Deleaval; Christie Lorriaux; Jean Marc Hurot; Brice Mayor; Manolie Mehdi; Charles Chazot
Journal:  PLoS One       Date:  2018-06-18       Impact factor: 3.240

7.  Variations of parathyroid hormone and bone biomarkers are concordant only after a long term follow-up in hemodialyzed patients.

Authors:  Pierre Delanaye; Xavier Warling; Martial Moonen; Nicole Smelten; François Jouret; Jean-Marie Krzesinski; Nicolas Maillard; Hans Pottel; Etienne Cavalier
Journal:  Sci Rep       Date:  2017-10-03       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.